# ProQR Therapeutics N.V. (PRQR): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for ProQR Therapeutics N.V. (PRQR) is 17/100, ranked against 24,000+ stocks in 35 markets (Quality 23, Value 31, Momentum 44, each scored against its sector).

- StockRank: 17/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 23, Value 31, Momentum 44: each a 0-100 percentile within Healthcare.
- Position: #22,256 overall, #2,002 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 1.29 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1.3M.

Source: https://moatmap.ai/stock/PRQR
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker